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INTRODUCTION
Hemorrhagic Fever with Renal Syndrome (HFRS) is an acute
infectious disease caused by Hantavirus. The clinical mani-
festations of HFRS comprise the triad of fever, hemorrhage,
and acute renal failure (1-3). The central physiologic derange-
ment in HFRS is widespread vascular dysfunction, leading
to impaired vascular tone and increased vascular permeabili-
ty (4-6). Therefore, the disease severity of HFRS depends on
the degree of vascular dysfunction (4). The clinical parameters
representing the severity of disease in patients with HFRS are
hypotension, severe acute renal failure, thrombocytopenia,
leukocytosis, hepatic dysfunction, and pleural effusion (4-6).
Besides these clinical factors, encephalopathy, sepsis, anuria,
acidosis, electrolyte abnormality, proteinuria of long duration,
increased hemoconcentration during hypotensive stage are
known to represent the severity of disease of HFRS (7-9).
Hypoalbuminemia frequently occurs in acute stage of HFRS.
Its mechanism seems to be multifactorial; increased catabolism
of protein, vascular leakage of serum protein due to increased
vascular permeability, loss of urinary protein, decreased intesti-
nal absorption of protein due to poor oral intake, and decreased
synthesis of albumin due to hepatic dysfunction. We have
previously reported that loss of protein via intestinal tracts was
common in HFRS, and it was associated with the level of serum
albumin and clinical parameters representing increased vas-
cular permeability (10). Generally, hypoalbuminemia is known
to be associated with complications and mortality in patients
with acute infectious disease (11). Based on the findings, we
hypothesized that hypoalbuminemia may be associated with
the disease severity in patients of HFRS, and we also studied
relationship between level of serum albumin and clinical param-
eters representing severity of disease (hypotension, severe acute
renal failure, thrombocytopenia, leukocytosis, hepatic dysfunc-
tion, and pleural effusion) in patients with HFRS.
MATERIALS AND METHODS
Study Population
One hundred forty-four patients with HFRS, who admit-
ted between January 1993 and December 2001 in Uijong-
bu St. Mary’ s Hospital, Uijongbu, Korea, were included in
this study. The diagnosis of HFRS was based on clinical man-
ifestations (high fever, flank pain, acute renal failure, protein-
uria, and thrombocytopenia) and indirect immunofluorescence
antibody test against the Hantavirus. The patients with chron-
ic liver disease, congestive heart failure, chronic renal failure,
hematologic disease, and inflammatory bowel disease were
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Serum Albumin Level Correlates with Disease Severity in Patients
with Hemorrhagic Fever with Renal Syndrome
Hypoalbuminemia frequently occurs in Hemorrhagic Fever with Renal Syndrome
(HFRS), but clinical significance of hypoalbuminemia is not well known. This study
was designed to evaluate hypoalbuminemia as a marker of severity of disease in
patients with HFRS. We evaluated the relationship between the level of serum albu-
min and clinical parameters representing the severity of disease in 144 patients with
HFRS. The patients were divided into three groups based on the level of serum albu-
min; Group I (normal serum albumin), Group II (serum albumin <3.5 g/dL and ≥3.0
g/dL), and Group III (serum albumin <3.0 g/dL). Of the total of 144 patients, 42 patients
(29.2%) were categorized as Group I, 39 patients (27.1%) as Group II, and 63 patients
(43.8%) as Group III. Group III had a higher rate of incidence in episode of hypoten-
sion, pulmonary edema than did Group I and Group II. The lowest level of serum
albumin was positively correlated with platelet count (r=0.505, p<0.001) and was
negatively correlated with leukocyte count (r=-0.329, p<0.001), BUN (r=-0.484, p<
0.001), serum creatinine (r=-0.394, p<0.001), and AST (r=-0.251, p=0.002). Our data
suggest that hypoalbuminemia frequently occurs in the acute stage of HFRS, and
level of serum albumin is associated with the disease severity of HFRS. 
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excluded. Out of the total 144 patients, 110 were male (76.4
%) and the mean age was 42±15 yr (range: 11-82 yr).
Study Design
We retrospectively studied medical records of the patients
with HFRS. We obtained medical records of clinical symp-
toms and signs and the following laboratory values from each
patient with HFRS; hemoglobin, hematocrit, platelet count,
leukocyte count, blood urea nitrogen (BUN), serum creatinine,
serum albumin level, serum aspartate aminotransferase (AST)
and alanine aminotransferase (ALT) levels, and proteinuria
and 24 hr urine protein amount. We also evaluated plain chest
and abdomen radiography and abdominal ultrasonography.
Finally, we investigated the episodes of hypotension, admis-
sion duration, and outcome from the patients. Hypotension
was defined as systolic pressure below 90 mmHg. Hypoal-
buminemia was defined as a serum albumin less than 3.5 g/
dL. Thrombocytopenia was defined as a platelet count below
100,000/ L. Leukocytosis was defined as a leukocyte count
over 10,000/ L. Acute renal failure was defined as a serum
creatinine over 2 mg/dL. Abnormal liver function was defined
as an AST or ALT over 80 IU/L. Platelet transfusion was per-
formed, when there was severe thrombocytopenia less than
50,000/ L or hemorrhagic manifestation or central vein
cannulation for hemodialysis in case of moderate thrombo-
cytopenia more than 50,000/ L. Hemodialysis treatment
was individualized according to the degree of acute renal fail-
ure and volume status. The patients were divided into three
groups based on the level of serum albumin; Group I (normal
serum albumin), Group II (serum albumin <3.5 g/dL and
≥3.0 g/dL), and Group III (serum albumin <3.0 g/dL). Lab-
oratory and clinical values were then compared among the
three groups, and the correlation between the lowest level of
serum albumin and laboratory values was evaluated.
Statistical Analysis
Data were expressed as mean±standard deviation (SD). The
differences among groups were analyzed by a one-way anal-
ysis of variance (ANOVA), followed by Schffe’ s test for mul-
tiple comparisons. Pearson’ s correlation coefficient was used
to determine the relationship between the lowest level of serum
albumin and laboratory values. The significance of differences
between proportions was tested by the chi-square test. Sta-
tistical significance was defined as p<0.05.
RESULTS
Clinical Characteristics
Indirect immunofluorescence antibody tests against the Han-
tavirus were positive in all patients. Fever developed in 128
(88.9%) patients, flank pain in 47 (32.6%), abdominal pain in
81 (56.3%), myalgia in 65 (45.1%), and headache in 44 (30.6
%). Episode of hypotension occurred in 29 (20.1%) patients.
Acute renal failure developed in 113 (78.5%) patients, and
55 patients of those (38.2%) received hemodialysis treatment.
Proteinuria (more than 1+ by urinalysis) developed in 115
(79.9%) patients, and it disappeared 7.3±8.2 days after admis-
sion. Quantitative measurement of urine protein performed
in 106 patients showed 1.9±1.6 g/day. Thrombocytopenia
developed in 118 (81.9%) patients, and 75 (52.1%) patients
received platelet transfusion. Abnormal liver function devel-
oped in 86 (59.7%) patients. Laboratory findings at admis-
sion are listed in Table 1. Pulmonary edema developed in 24
(16.7%) patients. Hemorrhage manifestation developed in
18 (12.5%) patients: gastrointestinal bleeding (n=9), nasal
bleeding (n=5), pulmonary hemorrhage (n=2), and intracra-
nial hemorrhage (n=1). Ten (6.9%) patients were expired due
to hypotensive shock (n=8), pulmonary hemorrhage (n=1),
and intracranial hemorrhage (n=1). Mean duration value of
the admission among the survivors (n=134) was 11.6±7.7
days (2-57 days).
Incidence of Hypoalbuminemia
The rate of incidence of hypoalbuminemia at admission
developed in 89 (61.8%) patients and increased up to 70.8%
after admission. The level of serum albumin at admission (3.2
±0.4 g/dL) also decreased to 3.1±0.4 g/dL after admission.
Based on the lowest level of serum albumin, 42 (29.2%) pa-
tients were categorized as Group I (normal serum albumin),
39 (27.1%) as Group II (serum albumin <3.5 g/dL and ≥3.0
g/dL), and 63 (43.8%) as Group III (serum albumin <3.0 g/
dL). The patients in Group III were older than those in Group
I (50±17 vs. 37±11, p<0.01) and Group II (50±17 vs. 36
±11 yr, p<0.05), but there was no statistical difference be-
tween Groups I and II. There was no statistical difference in
Hb, hemoglobin; Hct, hematocrit; WBC, white blood cell; Plt, platelet; BUN,
blood urea nitrogen; Scr, serum creatinine; AST, aspartate aminotrans-
ferase; ALT, alanine aminotrasferase; Alb, serum albumin; Upro, amount
of 24 hr urine protein.
Normal range Range Mean±SD
Hb (g/dL) 14.8±2.4 8.9-21.4 12-16
Hct (%) 43.5±7.4 26.9-63.7 34-49
WBC (x10
3/ L) 15.9±11.2 3.7-59.3 5-10
Plt (x10
3/L ) 7 0 ±69 8-341 150-450
BUN (mg/dL) 53.8±32.1 5.9-121.9 8-23
Scr (mg/dL) 5.1±3.4 0.6-12.9 0.5-1.2
AST (IU/L) 137±155 14-890 13-36
ALT (IU/L) 79±76 4-453 5-33
Alb (g/dL) 3.2±0.4 2.1-4.6 3.8-5.3
Upro (g/day) 1.93±1.66 0.10-7.01 <0.15
Table 1. Laboratory findings in 144 patients with HFRS at admis-
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sex ratio between 3 groups (male percent; 80.9%, 79.4%,
and 71.4%).
Correlation between the Lowest Level of Serum Albu-
min and Laboratory Values
The lowest level of serum albumin was positively correlat-
ed with platelet count (r=0.505, p<0.001), and was negative-
ly correlated with leukocyte count (r=-0.329, p<0.001), and
BUN (r=-0.484, p<0.001), and serum creatinine (r=-0.394,
p<0.001), and AST (r=-0.251, p=0.002). But there was no
correlation between the lowest level of serum albumin and
hemoglobin (r=0.058, p=0.491), hematocrit (r=0.050, p=
0.553), ALT (r=-0.120, p=0.153), and amount of 24 hr urine
protein (r=-0.090, p=0.361) (Fig. 1).
Comparison of Clinical Values and Mortality accord-
ing to the Lowest Level of Serum Albumin
The rate of incidence of hypotension in Group III was high-
er than that of Group I (0%) and that of Group II (7.6%). The
*group I vs. group II, p<0.05; 
� group I vs. group III, p<0.05; 
� group II vs.
group III, p<0.05.
Group III (n=63) Group II (n=39) Group I (n=42)
Hypotension (%) 0
� 7.6
� 41.2
ARF (%) 42.8*,� 94.8 92.1
Hemodialysis Tx (%) 0*,� 34.8
� 60.3
Thrombocytopenia (%) 54.7*,� 89.7 95.2
Platelet transfusion (%) 19.0*,� 58.9 69.8
Abnormal liver function (%) 42.8
� 64.1 68.2
Pulmonary edema (%) 0
� 2.5
� 36.5
Admission duration (day) 7.9±4.6
� 10.5±5.5
� 15.2±9.4
Death (%) 0
� 0
� 15.8
Table 2. The comparison of morbidity and mortality among the
three groups
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Fig. 1. The correlation between the lowest serum albumin level and Scr, leukocyte count, platelet count, and amount of proteinuria. The
lowest serum albumin level showed positive correlation with platelet count and negative correlation with Scr, leukocyte count. But there was
no correlation with the lowest serum level and amount of 24 hr urine protein. Scr, serum creatinine; Plt, platelet; Upro, amount of 24 hr urine
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rate of incidence of acute renal failure in Groups II (94.8%)
and III (92.1%) were higher than that of Group I (42.8%),
and while more patients from Group III (60.3%) received
hemodialysis treatment than did the patients from Group I
(0%) and Group II (34.8%). Group I had a higher rate of inci-
dence of thrombocytopenia and a higher incidence of platelet
transfusion, when compared to Group II and Group III. Group
I had a higher rate of incidence of abnormal liver function,
compared to group III, but there was no statistical difference
between Groups I and II. Group III had a higher rate of inci-
dence of pulmonary edema, when compared to Groups I and
II. All patients who were expired were in Group III, and the
duration of admission of the survivors from Group III (15.2
±9.4 days) was longer than that of Group I (7.9±4.6 days)
and that of Group II (10.5±5.5 days) (Table 2).
DISCUSSION
Hypoalbuminemia frequently occurs in the acute stage of
HFRS, but its significance is rarely reported until now. To
evaluate the relationship between the level of serum albumin
and the severity of disease in patients with HFRS, we have
studied 148 patents with HFRS in a single center. Our data
demonstrated that hypoalbuminemia frequently occurred in
the acute stage of HFRS, and the lowest level of serum albu-
min was associated with the severity of disease of HFRS. To
our knowledge, this is the first report demonstrating the rela-
tion between the level of serum albumin and the severity of
disease of HFRS.
Hemodynamic alterations leading to hypotension and shock
have been well characterized in patients with HFRS. These
alterations appear to be the consequence of widespread vascu-
lar dysfunction, including impaired vascular tone and increased
vascular permeability (4). Marked capillary congestion and
the episode of hypotension reflect the impairment of vascular
tone, while retroperitoneal edema, pleural effusion, ascites, and
pericardial effusion reflect the vascular leakage due to increased
vascular permeability (5). Increased vascular permeability has
been confirmed by tracer studies of blood and plasma volume
(12). Vascular endothelial cell injury is an important cause of
thrombocytopenia. Besides these clinical factors, severe acute
renal failure requiring hemodialysis, leukocytosis, abnormal
liver function, encephalopathy, sepsis, anuria, acidosis, elec-
trolyte abnormality, proteinuria of long duration, increased
hematocrit during hypotensive stage are reported to represent
the severity of disease of HFRS (4-9).
Although the mechanism of hypoalbuminemia in patients
with HFRS is not well known until now, it is considered to
be associated with protein leakage through the vessel wall due
to increased vascular permeability (4). We first demonstrat-
ed the loss of protein via intestinal tracts in the acute stage
of HFRS by abdominal scintigraphy using technetium-99m-
labeled human serum albumin and fecal clearance of alpha1-
antitrypsin and it was associated with serum albumin level
and clinical parameters representing increased vascular per-
meability (10). We also reported that hypoalbuminemia was
associated with gallbladder wall edema in the acute stage of
HFRS (13).
Based on these findings, we hypothesized that hypoalbu-
minemia in the acute stage of HFRS might be associated with
the increased vascular permeability in patients of HFRS. We
also studied the relationship between the level of serum albu-
min and clinical parameters representing the severity of dis-
ease. The lowest level of serum albumin was found to be asso-
ciated with clinical parameters representing the severity of
disease (hypotension, thrombocytopenia, leukocytosis, acute
renal failure, abnormal liver function, pulmonary edema, and
pleural effusion). Therefore, we suggest that hypoalbumin-
emia, which commonly occurs in acute stage of HFRS, is asso-
ciated with the severity of disease of HFRS.
We also evaluated whether the lowest level of serum albu-
min influences on the morbidity and mortality in patients with
HFRS. In this study, ten patients (6.9%) out of the total of
144 patients with HFRS died, and most of them (n=8) died
from hypotensive shock. This mortality ratio in patients with
HFRS was similar to other reports (2, 3, 14). To evaluate the
impact of serum albumin on the morbidity and mortality in
patients of HFRS, we divided the patients into three groups
based on the lowest level of serum albumin; Group I (normal
serum albumin), Group II (serum albumin <3.5 g/dL and ≥
3.0 g/dL), and Group III (serum albumin <3.0 g/dL). And
then we compared the factors among the three groups. Group
III had a higher rate incidence of episode of hypotension, pul-
monary edema, and pleural effusion than did other groups.
Duration of admission of survivors from Group III (15.2±
9.4 days) was longer than that of Group I (7.9±4.6 days) and
that of Group II (10.5±5.5 days). All ten patients who died
of HFRS were in Group III (p<0.01). Therefore, our data sug-
gest that the level of serum albumin is associated with mor-
bidity and mortality in patients with HFRS.
Interestingly, the amount of proteinuria did not correlate
with serum albumin level in this study. Furthermore, it was
not associated with the severity of renal failure. The loss of
urinary protein in patients with HFRS results from both tubu-
lar and glomerular injury (4, 15). Proteinuria frequently occurs
in the acute stage of with HFRS, but the amount of protein-
uria is usually mild and transient. In addition, it is reported
that the amount of proteinuria in patients with HFRS does
not correlate with the severity of renal biopsy findings (16).
In this study, the mean amount of proteinuria was 1.93±
1.66 g/day, and was similar to the other reports (17). It did
not correlate with the severity of renal failure and the level of
serum albumin. Furthermore, it completely disappeared in
most patients within 7 days. Therefore, we think, besides uri-
nary protein loss, that other factors such as intestinal protein
loss or increased catabolism of protein as a consequence of neg-
ative acute phase response of serum albumin may contribute700 Y.O. Kim, S.A. Yoon, Y.M. Ku, et al.
to hypoalbuminemia.
In conclusion, our data suggest that hypoalbuminemia fre-
quently occurs in the acute stage of HFRS and the lowest level
of serum albumin is closely associated with the clinical para-
meters representing disease severity and mortality. But it does
not correlate with the amount of proteinuria.
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